Hepatic posttranscriptional network comprised of CCR4–NOT deadenylase and FGF21 maintains systemic metabolic homeostasis
Author(s) -
Masahiro Morita,
Nadeem Siddiqui,
Sakie Katsumura,
Christopher Rouya,
Ola Larsson,
Takeshi Nagashima,
Bahareh Hekmatnejad,
Akinori Takahashi,
Hiroshi Kiyonari,
Mengwei Zang,
René StArnaud,
Yuichi Oike,
Vincent Giguère,
Ivan Topisirović,
Mariko Okada,
Tadashi Yamamoto,
Nahum Sonenberg
Publication year - 2019
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1816023116
Subject(s) - fgf21 , regulator , biology , energy homeostasis , adipose tissue , paracrine signalling , homeostasis , hormone , microbiology and biotechnology , endocrinology , fibroblast growth factor , biochemistry , receptor , obesity , gene
Significance The mRNA poly(A) tail controls gene expression at posttranscriptional levels, including mRNA degradation and translation. Here, we show that a hitherto unknown hepatic posttranscriptional network centered on the CCR4–NOT deadenylase plays a seminal role in regulating FGF21 expression and its effects on systemic metabolism. A genome-wide search for CNOT6L-associated mRNAs unveiled the mechanism whereby CNOT6L selectively degrades a subset of mRNAs encoding metabolic factors, including FGF21. Disruption of CCR4–NOT deadenylase activity, by targeting its catalytic subunit CNOT6L, leads to an increase in FGF21 levels, which is paralleled by a dramatic improvement of metabolic syndrome. Overall, our findings describe a new paradigm in regulation of whole-body metabolism, whereby a hepatic posttranscriptional network governs systemic metabolic regulation via FGF21.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom